MasTec, Inc. MTZ 深 滬
等待開盤 10-08 09:30:00 美东时间
213.08
-3.720
-1.72%
華盛通- 最 高220.75
- 今 開218.44
- 成交量 56.75万股
- 最 低 207.98
- 昨 收 216.80
- 總市值 168.14亿
- 52周最高 221.83
- 市盈率 靜 103.25
- 換手率 0.72%
- 52周最低 99.70
- 委 比 -53.85%
- 總股本 7890.80万
- 歷史最高 221.83
- 量 比 0.88
- 振 幅 5.89%
- 歷史最低 12.435
- 每 手 1
- 風險率 25.37%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Bowman acquires Sierra Overhead Analytics, expanding engineering services
Bowman Consulting Group (NASDAQ:BWMN) said on Monday that it has acquired the assets of California-based Sierra Overhead Analytics and its technology affiliate ORCaS, two companies under common contro...
10-06 20:17
美股大行评级 | 潜在涨幅1176.6%！Ascendiant Capital上调Society Pass目标价至18美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从15美元升至18美元；Ascendiant Capital：维持Surgepays"买入"评级，目标价从9美元升至9.5美元
10-06 08:35
The Analyst Verdict: MasTec In The Eyes Of 15 Experts
In the last three months, 15 analysts have published ratings on MasTec (NYSE:MT...
10-04 02:01
P/E Ratio Insights for MasTec
In the current session, the stock is trading at $216.84, after a 0.67% increase...
10-04 02:01
Citigroup Maintains Buy on MasTec, Raises Price Target to $248
Citigroup analyst Andrew Kaplowitz maintains MasTec (NYSE:MTZ) with a Buy and raises the price target from $219 to $248.
10-03 22:55
美股大行评级 | 潜在涨幅162.68%！Ocular Therapeutix获JMP证券升目标价至29美元，维持"跑赢大市"评级
今日重点评级关注：JMP证券：维持Ocular Therapeutix"跑赢大市"评级，目标价从20美元升至29美元；汇丰银行：上调Banco BBVA Argentina评级至"买入"，目标价从21美元下调至17美元
10-02 15:08
美股大行评级 | 星展银行上调百度评级至"买入"，目标价177美元；多家机构上调Guardant Health(GH)目标价最高至80美元
今日重点评级关注：Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12美元升至12.5美元；Oppenheimer：维持Immuneering"跑赢大市"评级，目标价从21美元升至30美元
09-26 09:45
Roth Capital Maintains Buy on MasTec, Raises Price Target to $250
Roth Capital analyst Philip Shen maintains MasTec (NYSE: MTZ) with a Buy and raises the price target from $210 to $250.
09-26 02:05
$1000 Invested In MasTec 5 Years Ago Would Be Worth This Much Today
MasTec (NYSE:MTZ) has outperformed the market over the past 5 years by 21.98% o...
09-20 05:31
美股大行评级 | Tigress Financial：维持苹果"强烈买入"评级，目标价升至305美元；杰富瑞维持百度"买入"评级，目标价升至157美元
今日重点评级关注：HC Wainwright & Co.：维持Astria Therapeutics"买入"评级，目标价从16美元升至20美元；HC Wainwright & Co.：维持Avalo Therapeutics"买入"评级，目标价从15美元升至25美元
09-18 10:13
